WallStSmart

Coca-Cola European Partners PLC (CCEP)vsYoulife Group Inc. American Depositary Shares (YOUL)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 636% more annual revenue ($21.35B vs $2.90B). CCEP leads profitability with a 9.3% profit margin vs 1.2%. YOUL trades at a lower P/E of 2.1x. CCEP earns a higher WallStSmart Score of 46/100 (D+).

CCEP

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 7.0Value: 3.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

YOUL

Hold

43

out of 100

Grade: D

Growth: 7.3Profit: 3.5Value: 6.7Quality: 7.0
Piotroski: 2/9Altman Z: 2.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPSignificantly Overvalued (-87.1%)

Margin of Safety

-87.1%

Fair Value

$52.17

Current Price

$116.13

$63.96 premium

UndervaluedFair: $52.17Overvalued

Intrinsic value data unavailable for YOUL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP2 strengths · Avg: 9.5/10
Return on EquityProfitability
42.7%10/10

Every $100 of equity generates 43 in profit

Market CapQuality
$50.97B9/10

Large-cap with strong market position

YOUL4 strengths · Avg: 9.8/10
P/E RatioValuation
2.1x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
114.8%10/10

Revenue surging 114.8% year-over-year

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

PEG RatioValuation
3.172/10

Expensive relative to growth rate

YOUL4 concerns · Avg: 3.0/10
Market CapQuality
$10.45M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.4%3/10

ROE of 6.4% — below average capital efficiency

Profit MarginProfitability
1.2%3/10

1.2% margin — thin

Operating MarginProfitability
1.6%3/10

Operating margin of 1.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity, Market Cap.

Bull Case : YOUL

The strongest argument for YOUL centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 114.8% demonstrates continued momentum.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : YOUL

The primary concerns for YOUL are Market Cap, Return on Equity, Profit Margin. Thin 1.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

CCEP profiles as a value stock while YOUL is a hypergrowth play — different risk/reward profiles.

YOUL is growing revenue faster at 114.8% — sustainability is the question.

CCEP generates stronger free cash flow (604M), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCEP scores higher overall (46/100 vs 43/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Youlife Group Inc. American Depositary Shares

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Youlife Group Inc. (Ticker: YOUL) is a dynamic player in the global health and wellness industry, specializing in innovative lifestyle products and personalized health solutions aimed at enhancing quality of life. The company's commitment to sustainability and community engagement resonates with the increasing consumer focus on wellness and preventive care, unlocking significant market potential. With strong strategic partnerships and a focus on research and development, Youlife is well-positioned to capitalize on emerging growth opportunities, making it an attractive investment for institutional investors seeking to navigate the changing landscape of health and wellness.

Want to dig deeper into these stocks?